Melanotan-1 Dosing Protocol: Cycling, Frequency & Best Practices

Introduction

The real Melanotan-1 dosing protocol is simple: a clinician places a 16 mg implant under the skin roughly every two months. That is the approved schedule for afamelanotide, and it looks nothing like the injection regimens promoted in online tanning and peptide communities. Getting this distinction right is the whole point of this article.

Melanotan-1, sold as afamelanotide under the brand Scenesse, is not a self-dosed peptide. It is a prescription implant administered by trained clinicians for a specific rare disorder. The dosing information below describes how the approved drug is actually used and explains why the homebrew injection protocols you may have seen do not apply to it. Honesty here protects readers from a genuinely risky practice.

At TrimRx, we believe understanding how a compound is properly dosed, and by whom, is the first step toward an honest conversation about your health. If your interest is evidence-based metabolic care, our free assessment quiz is a quick place to start.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

What Is the Approved Melanotan-1 Dose?

The approved dose is a single 16 mg afamelanotide implant inserted subcutaneously, typically every 60 days during periods of higher light exposure. This is the dosing established in the clinical trials that led to FDA approval in 2019.

Quick Answer: The only legitimate Melanotan-1 dosing protocol is the approved afamelanotide implant: 16 mg placed under the skin by a clinician, usually every 60 days.

The implant is a small bioresorbable rod placed under the skin, usually above the hip bone, in a brief in-office procedure. It dissolves on its own over time, so it does not need removal. The 60-day interval reflects how long meaningful drug levels persist. There is no titration in the way GLP-1 drugs are escalated, because the implant delivers a fixed dose by design. This fixed, clinician-administered approach is the entire approved protocol. Anything more complicated than “an implant every couple of months from your clinician” is not the approved regimen.

How Often Is Melanotan-1 Dosed?

About every 60 days, and only during periods when extra light protection is needed. For people with erythropoietic protoporphyria, that often means seasonal dosing timed to months with more daylight.

The two-month interval comes directly from the slow-release design of the implant. As the implant bioresorbs, drug levels gradually fall, and the protective pigmentation fades over the following weeks. Re-implanting on schedule maintains the effect. Because the drug is for a chronic condition, dosing can continue for years under a clinician’s direction, but always on this implant-based cadence. There is no version of the approved drug that involves daily or weekly dosing. If you see a protocol describing daily Melanotan injections, it is describing the unregulated product, not afamelanotide.

Is There a Melanotan-1 Cycling Protocol?

Not for the approved drug. The implant is dosed on a clinical schedule tied to light exposure, not in the on-and-off “cycles” that online peptide culture describes. Those cycling protocols come from the gray-market injectable scene, not from medicine.

The cycling idea usually involves a “loading phase” of frequent injections followed by less frequent “maintenance” doses to build and keep a tan. This entire framework applies to unregulated injectable Melanotan, often Melanotan-2 or unverified material, and has no connection to how afamelanotide is actually used. There is no medical evidence supporting these schedules, no quality control over the product, and no monitoring for the skin changes the drug can cause. So the honest answer is that the cycling protocols you find online are not a legitimate way to dose Melanotan-1. They are a description of a risky underground practice.

Why Is There No Home-injection Protocol?

Melanotan-1 has no approved home-injectable form because it was developed and approved specifically as a clinician-placed implant. The slow-release implant provides steady, controlled dosing that self-injection cannot match.

The implant design was chosen for good reasons. It delivers a consistent dose over two months, removes the variability of self-injection, and keeps the patient connected to clinical care that includes skin monitoring. Self-injected Melanotan products bypass all of that. They have unknown purity, no standardized dose, and no oversight, which is exactly the combination that has led to documented harms including mole changes and, in case reports, melanoma. The absence of a home-injection protocol is not an oversight. It reflects a deliberate choice to keep this drug within supervised care.

What Monitoring Goes with Proper Dosing?

Skin and mole examinations are part of any responsible Melanotan-1 dosing plan, because the drug darkens pigment cells, including existing moles. A baseline skin check and periodic dermatologic review are standard with the approved implant.

This monitoring is inseparable from the dosing itself. Because afamelanotide is administered by clinicians, patients stay within a system that watches for the pigment-related changes the drug can produce. That ongoing surveillance is part of what makes long-term use reasonable. With unsupervised injectable Melanotan, this monitoring disappears, which is the single biggest safety gap. A dosing protocol without skin monitoring is incomplete for any melanocortin agent, and the approved implant builds that monitoring in by keeping a clinician involved at every dose.

Key Takeaway: The implant uses slow release over about two months, so there is no daily or weekly dosing schedule.

How Is the Implant Actually Placed?

The afamelanotide implant is inserted under the skin during a short in-office visit, usually just above the hip bone. A clinician numbs the area, uses a specialized applicator to place the small rod beneath the skin, and the procedure is done in minutes.

No stitches are needed, because the implant is bioresorbable and the insertion site is tiny. Patients can typically return to normal activity right away. The simplicity of the placement is part of why the implant format works well for a chronic, repeat-dosed therapy. Compared with frequent self-injection, a brief clinic visit every two months is both more reliable and safer, since each visit keeps the patient in contact with the care team. This procedural detail is another reason the approved drug looks nothing like the at-home injection routines promoted for gray-market Melanotan.

What Does Proper Melanotan-1 Dosing Cost and Require?

Because afamelanotide is a specialty prescription drug for a rare disease, it requires a diagnosis, a prescribing specialist, and clinic visits for each implant. It is not an over-the-counter or self-ordered product, and pricing is handled through specialty pharmacy and insurance channels rather than published retail rates.

This structure is part of the dosing reality. You cannot simply buy and self-administer the approved drug. Access runs through dermatology or specialty centers familiar with EPP, and the cost reflects its status as an orphan drug for a small patient population. For most people who encounter “Melanotan” online, none of this applies, because what they are looking at is not afamelanotide at all. The gap between a supervised specialty implant and a vial of unverified peptide is enormous, and it is exactly the gap that makes online dosing protocols misleading.

What Are the Best Practices for Legitimate Use?

The best practice is straightforward: use only the approved implant, only under a qualified clinician, with skin monitoring and a clear medical indication. For Melanotan-1, there is no responsible do-it-yourself version.

If you have EPP, work with a specialist who can confirm candidacy, place the implants on the correct schedule, and monitor your skin over time. Keep up other photoprotection measures, since the drug reduces but does not eliminate light sensitivity. If you do not have EPP and were considering Melanotan for tanning or other goals, the honest best practice is to avoid the gray-market products entirely and discuss safer, better-studied alternatives with a clinician. The defining feature of good Melanotan-1 dosing is medical supervision, and any protocol that removes it is not best practice no matter how detailed it looks.

Path Forward with Supervised Care

The clear lesson on Melanotan-1 dosing is that the only legitimate protocol is a clinician-placed implant with monitoring attached, and that the self-injection regimens online belong to a separate, unregulated world. At TrimRX, our focus is on FDA-regulated and personalized compounded therapies for metabolic health, always prescribed and monitored by licensed providers, never self-dosed from gray-market sources. If you came here researching peptides and want help telling proper medical dosing from internet protocols, the free assessment quiz takes only a few minutes.

FAQ

What Is the Approved Dose of Melanotan-1?

A single 16 mg afamelanotide implant placed under the skin by a clinician, usually every 60 days during periods of higher light exposure.

How Often Is Melanotan-1 Dosed?

About every two months, and only when extra light protection is needed. For EPP, this is often seasonal. There is no daily or weekly approved schedule.

Is There a Melanotan-1 Cycling Protocol?

Not for the approved drug. Cycling protocols online describe unregulated injectable Melanotan, not afamelanotide, and are not supported by medical evidence.

Can I Inject Melanotan-1 at Home?

There is no approved home-injectable Melanotan-1. The approved product is a clinician-placed implant. Injectable products sold online are unregulated and not the same.

Why Does the Implant Last Two Months?

It is a slow-release, bioresorbable implant designed to release afamelanotide gradually over about 60 days, which sets the dosing interval.

What Monitoring Is Needed with Melanotan-1?

Baseline and periodic skin and mole checks, because the drug darkens pigment cells. This monitoring is built into the supervised use of the approved implant.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.